Laurus Labs Limited Laurus Labs Limited

Laurus Labs Limited

LAURUSLABS

Pozycja w akcjach #1739
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Cena akcji
$22.83
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$12.34B
Zmiana (1 dzień)
0.51%
Zmiana (1 rok)
117.95%
Kraj
IN
Handel Laurus Labs Limited (LAURUSLABS)

Kategoria

Healthcare
Historia podziałów akcji dla Laurus Labs Limited (LAURUSLABS)
Akcje Laurus Labs Limited (symbol: LAURUSLABS) przeszły łącznie 1 podziałów.
Najnowszy podział miał miejsce Sep 29, 2020.
Jedna akcja LAURUSLABS kupiona przed Sep 29, 2020 odpowiada dziś 5 akcjom LAURUSLABS.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
2020-09-29 5:1 x5 x5
Podziały akcji dla podobnych firm lub konkurencji